Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAMPIN vs RILONACEPT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIFAMPIN vs RILONACEPT: Safety Overview

Metric RIFAMPIN RILONACEPT
Total FAERS Reports 13,347 843
Deaths Reported 1,439 14
Death Rate 10.8% 1.7%
Hospitalizations 5,764 65
Average Patient Age 51.7 yrs 51.9 yrs
% Female Patients 47.8% 68.2%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. Kiniksa Pharmaceuticals (UK), Ltd.
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Discontinued Prescription